genotropin pen

Genotropin Pfizer 1 vial [1x36IU]

$216.16

SKU: 24-7.is5993_ Categories: ,
pfizer

Description

IMPORTANT

THIS PRODUCT ARE SHIPPED FROM EU ETA : 10-14 DAYS. IF YOU MIX WITH DOMESTIC US HUTECH LABS, THEN WE WILL SEND ALL FROM EU. IF YOU ONLY CHOOSE HUTECH LABS ETA IS 1-3 DAYS DOMESTIC ONLINE USA.

Brand

Pfizer

Pfizer Inc. (NYSE:PFE) today announced that the European Commission approved TALZENNA® (talazoparib), an oral poly (ADP-ribose) polymerase (PARP) inhibitor, as monotherapy for the treatment of adult patients with germline breast cancer susceptibility gene (gBRCA)1/2-mutations, who have human epidermal growth factor receptor 2-negative (HER2-) locally advanced (LA) or metastatic breast cancer (MBC). Patients should have been previously treated with an anthracycline and/or a taxane in the (neo)adjuvant, locally advanced or metastatic setting unless patients were not suitable for these treatments. Patients with hormone receptor-positive (HR+) breast cancer should have been treated with a prior endocrine-based therapy, or be considered unsuitable for endocrine-based therapy. This approval follows the medicine’s approval by the U.S. Food and Drug Administration (FDA) in October 2018.
pfizer

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.